Results TuesdayToday 12:41
Join us for EMV Capital's upcoming Final Results Presentation for the year ended 31 December 2025, on Tuesday 19 May at 10:30 BST.
CEO ILIAN ILIEV, CFO Anesh Patel, and Executive Director Edward Hooper will present full year results, sharing significant portfolio progress across both the EMV Capital EIS Fund and the Martlet Capital Fund.
Management will also discuss the Group's Venture Build programme and broader strategy of active portfolio management, scalable fee-generating activities and exposure to sectors addressing major global challenges.
Let's hope 'significant portfolio progress' gets the share price moving again. Might be worth a trade on Monday?
I've added up the last valuations and get to £17M+ for our % holdings plus £3.6M for EMV Capital, so £21M vs £12.5M MCap at 45p.
We also have Glycotest at £11M and ProAxis at £8M on the books. No idea what these are really worth as zero news to follow. The Glycotest 6 year trial should have come to an end by now but god only knows what value it has.